Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients (JUNOVO)
Prospective, Non-interventional Study to Evaluate the Efficacy and Safety of NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients With Closed Epiphyses
Sponsor: Aesculap AG
Listed as NCT04186208, this observational or N/A phase trial focuses on Cartilage Disease and remains ongoing. Sponsored by Aesculap AG, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
May 2022 — Dec 2023 [monthly]
Active Not Recruiting
▶ Show 4 earlier versions
-
Nov 2021 — May 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
May 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2020 — May 2020 [monthly]
Recruiting
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aesculap AG
- Tetec AG
- Winicker Norimed GmbH
For direct contact, visit the study record on ClinicalTrials.gov .